ARTICLE | Clinical News
AC2993: Phase II
January 17, 2000 8:00 AM UTC
AMLN reported additional results from a previously reported 24-patient crossover study showing that AC2993 reduced post-meal increases in triglycerides and glucagon and slowed nutrient release from th...